Max Healthcare Institute Share Price
Sector: Healthcare Facilities
1166.00 -20.70 (-1.74%)
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- 5Y
- MAX
Price Range
Today’s Low
1158.70
Today’s High
1197.35
52 Week Low
743.00
52 Week High
1227.50
1167.10 -19.40 (-1.64%)
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- 5Y
- MAX
Price Range
Today’s Low
1158.60
Today’s High
1196.90
52 Week Low
743.10
52 Week High
1227.95
Key Metrics
- Market Cap (In Cr) 113037.43
- Beta 0.77
- Div. Yield (%) 0.13
- P/B 13.49
- TTM P/E 108.73
- Sector P/E 23.18
- Open Price 1187.25
- Prev Close 1186.7
Max Healthcare Institute Analysis
Price Analysis
-
1 Week3.49%
-
3 Months16.29%
-
6 Month15.99%
-
YTD3.45%
-
1 Year37.46%
Risk Meter
- 40% Low risk
- 40% Moderate risk
- 40% Balanced Risk
- 40% High risk
- 40% Extreme risk
Recos
- Strong Sell
- Sell
- Hold
- Buy
- Strong Buy
Analysts' Views
- Ratings
- Current
- 1 W Ago
- 1 M Ago
- 3 M Ago
- Strong Buy
- 6
- 6
- 6
- 6
- Buy
- 7
- 7
- 7
- 6
- Hold
- 3
- 3
- 3
- 3
- Sell
- 4
- 4
- 4
- 4
- Strong Sell
- 0.00
- 0.00
- 0.00
- 0.00
- Total
- 20
- 20
- 20
- 19
Max Healthcare Institute News
Breakout stocks to buy or sell: Sumeet Bagadia recommends five shares to buy
1 min read . 07 Apr 2025Buy or sell: Vaishali Parekh recommends three stocks to buy today — 4 April 2025
2 min read . 04 Apr 2025Buy or sell stocks: Vaishali Parekh recommends three shares for today — Jan 21
3 min read . 21 Jan 2025Sagar Doshi of Nuvama recommends these 3 stocks to buy today- 8 January
3 min read . 08 Jan 2025Max Healthcare Institute Financials
- INCOME
- BALANCE SHEET
- Cashflow
- Period
- 2024
- Total Revenue
- 5406.02
- Selling/ General/ Admin Expenses Total
- 2698.1
- Depreciation/ Amortization
- 244.92
- Other Operating Expenses Total
- 8.22
- Total Operating Expense
- 4146.86
- Operating Income
- 1259.16
- Net Income Before Taxes
- 1365.32
- Net Income
- 1057.64
- Diluted Normalized EPS
- 10.83
- Period
- 2024
- Total Assets
- 11999.94
- Total Liabilities
- 3591.8
- Total Equity
- 8408.14
- Tangible Book Valueper Share Common Eq
- 29.07
- Period
- 2024
- Cashfrom Operating Activities
- 1156.52
- Cashfrom Investing Activities
- -1285.45
- Cashfrom Financing Activities
- -263.74
- Net Changein Cash
- -394.49
- Period
- 2023
- Total Revenue
- 4562.6
- Selling/ General/ Admin Expenses Total
- 2322.24
- Depreciation/ Amortization
- 232.19
- Other Operating Expenses Total
- 5.69
- Total Operating Expense
- 3551.05
- Operating Income
- 1011.55
- Net Income Before Taxes
- 1063.72
- Net Income
- 1103.51
- Diluted Normalized EPS
- 11.35
- Period
- 2023
- Total Assets
- 10101.85
- Total Liabilities
- 2692.26
- Total Equity
- 7409.59
- Tangible Book Valueper Share Common Eq
- 24.14
- Period
- 2023
- Cashfrom Operating Activities
- 1209.18
- Cashfrom Investing Activities
- -1187.01
- Cashfrom Financing Activities
- -288.56
- Net Changein Cash
- -266.39
- Period
- 2022
- Total Revenue
- 3931.46
- Selling/ General/ Admin Expenses Total
- 1981.15
- Depreciation/ Amortization
- 221.12
- Other Operating Expenses Total
- 3.81
- Total Operating Expense
- 3200.68
- Operating Income
- 730.78
- Net Income Before Taxes
- 738.9
- Net Income
- 605.05
- Diluted Normalized EPS
- 6.34
- Period
- 2022
- Total Assets
- 9189.13
- Total Liabilities
- 2906.66
- Total Equity
- 6282.47
- Tangible Book Valueper Share Common Eq
- 12.09
- Period
- 2022
- Cashfrom Operating Activities
- 748.49
- Cashfrom Investing Activities
- -771.77
- Cashfrom Financing Activities
- -294.17
- Net Changein Cash
- -317.45
- Period
- 2021
- Total Revenue
- 2504.67
- Selling/ General/ Admin Expenses Total
- 1447.92
- Depreciation/ Amortization
- 174.09
- Other Operating Expenses Total
- 6.87
- Total Operating Expense
- 2508.36
- Operating Income
- -3.69
- Net Income Before Taxes
- -68.65
- Net Income
- -137.55
- Diluted Normalized EPS
- 0.17
- Period
- 2021
- Total Assets
- 8544.44
- Total Liabilities
- 2905.76
- Total Equity
- 5638.68
- Tangible Book Valueper Share Common Eq
- 8.8
- Period
- 2021
- Cashfrom Operating Activities
- 397.25
- Cashfrom Investing Activities
- -73
- Cashfrom Financing Activities
- 191.33
- Net Changein Cash
- 515.58
- Period
- 2020
- Total Revenue
- 1884.46
- Selling/ General/ Admin Expenses Total
- 1172.06
- Depreciation/ Amortization
- 119.74
- Other Operating Expenses Total
- -7.93
- Total Operating Expense
- 1714.58
- Operating Income
- 169.88
- Net Income Before Taxes
- 89.08
- Net Income
- 95.34
- Diluted Normalized EPS
- 1.05
- Period
- 2020
- Total Assets
- 3824.38
- Total Liabilities
- 2836.97
- Total Equity
- 987.41
- Tangible Book Valueper Share Common Eq
- -2.74
- Period
- 2020
- Cashfrom Operating Activities
- 249.82
- Cashfrom Investing Activities
- -126.68
- Cashfrom Financing Activities
- 144.05
- Net Changein Cash
- 267.19
- Period
- 2019
- Total Revenue
- 1691.02
- Selling/ General/ Admin Expenses Total
- 1119.93
- Depreciation/ Amortization
- 102.64
- Other Operating Expenses Total
- 2.87
- Total Operating Expense
- 1636.96
- Operating Income
- 54.06
- Net Income Before Taxes
- 8.32
- Net Income
- -3.01
- Diluted Normalized EPS
- -0.03
- Period
- 2019
- Total Assets
- 3365.62
- Total Liabilities
- 2402.43
- Total Equity
- 963.19
- Tangible Book Valueper Share Common Eq
- -3.21
- Period
- 2019
- Cashfrom Operating Activities
- 88.95
- Cashfrom Investing Activities
- -16.53
- Cashfrom Financing Activities
- -73.95
- Net Changein Cash
- -1.53
- Period
- 2024-12-31
- Total Revenue
- 1868.31
- Selling/ General/ Admin Expenses Total
- 690.74
- Depreciation/ Amortization
- 97.54
- Other Operating Expenses Total
- 286.62
- Total Operating Expense
- 1540.35
- Operating Income
- 327.96
- Net Income Before Taxes
- 308.87
- Net Income
- 238.8
- Diluted Normalized EPS
- 3.02
- Period
- 2024-12-31
- Period
- 2024-12-31
- Period
- 2024-09-30
- Total Revenue
- 1707.46
- Selling/ General/ Admin Expenses Total
- 638.32
- Depreciation/ Amortization
- 84.15
- Other Operating Expenses Total
- 269.36
- Total Operating Expense
- 1341.07
- Operating Income
- 366.39
- Net Income Before Taxes
- 373.69
- Net Income
- 281.81
- Diluted Normalized EPS
- 2.88
- Period
- 2024-09-30
- Total Assets
- 13126.87
- Total Liabilities
- 4327.81
- Total Equity
- 8799.06
- Tangible Book Valueper Share Common Eq
- 33.68
- Period
- 2024-09-30
- Cashfrom Operating Activities
- 576.02
- Cashfrom Investing Activities
- -569.94
- Cashfrom Financing Activities
- -21.73
- Net Changein Cash
- -15.88
- Period
- 2024-06-30
- Total Revenue
- 1542.95
- Selling/ General/ Admin Expenses Total
- 597.72
- Depreciation/ Amortization
- 76.9
- Other Operating Expenses Total
- 231.26
- Total Operating Expense
- 1232.44
- Operating Income
- 310.51
- Net Income Before Taxes
- 321.31
- Net Income
- 236.27
- Diluted Normalized EPS
- 2.42
- Period
- 2024-06-30
- Period
- 2024-06-30
- Period
- 2024-03-31
- Total Revenue
- 1422.9
- Selling/ General/ Admin Expenses Total
- 534.39
- Depreciation/ Amortization
- 70.32
- Other Operating Expenses Total
- 211.38
- Total Operating Expense
- 1111.69
- Operating Income
- 311.21
- Net Income Before Taxes
- 335.73
- Net Income
- 251.54
- Diluted Normalized EPS
- 2.57
- Period
- 2024-03-31
- Total Assets
- 11999.94
- Total Liabilities
- 3591.8
- Total Equity
- 8408.14
- Tangible Book Valueper Share Common Eq
- 29.07
- Period
- 2024-03-31
- Cashfrom Operating Activities
- 1156.52
- Cashfrom Investing Activities
- -1285.45
- Cashfrom Financing Activities
- -263.74
- Net Changein Cash
- -394.49
- Period
- 2023-12-31
- Total Revenue
- 1334.97
- Selling/ General/ Admin Expenses Total
- 506.73
- Depreciation/ Amortization
- 60.96
- Other Operating Expenses Total
- 175.1
- Total Operating Expense
- 1010.07
- Operating Income
- 324.9
- Net Income Before Taxes
- 359.68
- Net Income
- 289.34
- Diluted Normalized EPS
- 2.97
- Period
- 2023-12-31
- Period
- 2023-12-31
Forecast
Income Sheet (In Cr)
Net Income Vs Revenue
Returns Metrics (In Cr)
ROA Vs ROE
Forecast
Balance Sheet
Asset vs Liability
Forecast
Cash Flow
Operating vs Investing
Max Healthcare Institute Technical
Moving Average
SMA
- 5 Day1172.82
- 10 Day1153.92
- 20 Day1126.19
- 50 Day1088.44
- 100 Day1090.29
- 300 Day1027.15
Max Healthcare Institute Peers
- Price
- Ratio
- Name
- Latest Price
- Change
- % Change
- 52W High
- 52W Low
- Mkt. Cap
- Max Healthcare Institute
- 1166
- -20.7
- -1.74
- 1227.5
- 743
- 113037.43
- Apollo Hospitals Enterprise
- 7000
- -71.3
- -1.01
- 7545.1
- 5690.8
- 100649.26
- Fortis Healthcare
- 700.3
- 0.35
- 0.05
- 744
- 406.35
- 52869.72
- Narayana Hrudayalaya
- 1772
- -19.15
- -1.07
- 1872.85
- 1087.8
- 36322.24
- Global Health
- 1202.65
- -40.55
- -3.26
- 1430
- 936.05
- 32361.53
- Name
- P/E (X)
- P/B (X)
- ROE %
- OPM
- Max Healthcare Institute
- 107.72
- 13.49
- 10.89
- 15.02
- Apollo Hospitals Enterprise
- 112.1
- 14.54
- 13.57
- 4.82
- Fortis Healthcare
- 90.45
- 6.9
- 5.07
- 7.63
- Narayana Hrudayalaya
- 45.41
- 12.58
- 23.44
- 9.72
- Global Health
- 62.23
- 9.53
- 14.18
- 11.38
Max Healthcare Institute Shareholding
Shareholding Pattern
Shareholding Trend
Shareholding(%) v/s Date
Corporate Actions
- Board Meeting
- AGM
- Dividends
- Bonus
- Split
- Rights
- Meeting Date
- Purpose
- 20-May-25
- Audited Results & Final Dividend
- 30-Jan-25
- Quarterly Results
- 05-Nov-24
- Quarterly Results
- 01-Aug-24
- Quarterly Results
- 22-May-24
- Audited Results & Final Dividend
- 31-Jan-24
- Quarterly Results
- 06-Nov-23
- Quarterly Results
- 07-Aug-23
- Quarterly Results
- 16-May-23
- Audited Results & Final Dividend
- 02-Feb-23
- Quarterly Results & Others
- Meeting Date
- Announced on
- Purpose
- 20-Sept-24
- 12-Aug-24
- AGM
- 27-Sept-23
- 23-Aug-23
- AGM
- 17-Aug-23
- 17-Jul-23
- POM
- 26-Sept-22
- 31-Aug-22
- AGM
- 07-May-22
- 04-Apr-22
- POM
- 30-Sept-21
- 10-Aug-21
- AGM
- Announced on
- Record Date
- Ex-Dividend
- Dividend Value
- 22-May-24
- 23-Aug-24
- 23-Aug-24
- 1.5
- 16-May-23
- 08-Sept-23
- 08-Sept-23
- 1


